Total Voting Rights

RNS Number : 6315W
Hutchison China Meditech Limited
02 February 2012
 



 

 

 

 

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

 

 

Total Voting Rights

 

 

London: Thursday, 2 February 2012: For information purposes, Chi-Med hereby notifies the market that as at 31 January 2012, the issued share capital of the Company consisted of 51,794,365 ordinary shares of US$1.00 each, with each share carrying one right to vote and with no shares held in treasury.

 

The above figure of 51,794,365 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Chi-Med under the FSA's Disclosure and Transparency Rules.

 

 

Ends

Enquiries

 

Chi-Med

Christian Hogg, CEO

Telephone:      +852 2121 8200

 



Citigate Dewe Rogerson

Anthony Carlisle

David Dible

Telephone:      +44 20 7638 9571

Mobile:             +44 7973 611 888

Mobile:             +44 7967 566 919



Lazard & Co., Limited

Paul Gismondi

Nick Fowler

Telephone:      +44 20 7187 2000

 

 

About Chi-Med

 

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

 

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREAKAFEAAAEFF
UK 100

Latest directors dealings